This document summarizes findings from surveys of sponsors and clinical research organizations (CROs) regarding quality in outsourced clinical trials. Key findings include: sponsors and CROs report moderate satisfaction with quality; cost pressures are a primary cause of quality issues; and proactive communication of quality expectations between sponsors and CROs is still lacking. Practices associated with higher quality and satisfaction include use of quality metrics and agreements. Risk-based approaches to monitoring and regional differences in quality were also discussed. Developing quality standards through collaboration between sponsors and CROs shows potential to improve outcomes.